Company / Total Assets
Cardiff Oncology, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$61.9M
FY2025
5-year range
$61.9M / $149.5M
FY2021-FY2025
Trend
-36.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 10 years, ranging from $12M in FY2017 to $150M in FY2021.
Based on SEC 10-K filings.
$62M in FY2025 with a 5-year CAGR of -14.4%.
Declined from $82M to $62M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -18.9%
- 5-Year CAGR
- -14.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -14.4%, indicating a declining trend.
- In FY2025, total assets decreased 36.3% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.9M | -36.3% |
| FY2024 | $97.2M | +19.1% |
| FY2023 | $81.6M | -29.7% |
| FY2022 | $116.2M | -22.3% |
| FY2021 | $149.5M | +11.0% |
| FY2020 | $134.7M | +929.5% |
| FY2019 | $13.1M | -7.7% |
| FY2018 | $14.2M | +15.4% |
| FY2017 | $12.3M | -72.0% |
| FY2016 | $44.0M | -38.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026